

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sensory perception of smell (GO:0007608) | 7.37208387 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36846624 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36846624 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.36846624 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36846624 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.36846624 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36846624 |
| 8 | low-density lipoprotein particle clearance (GO:0034383) | 4.21401792 |
| 9 | sensory perception of chemical stimulus (GO:0007606) | 3.93388073 |
| 10 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.80885424 |
| 11 | regulation of cholesterol storage (GO:0010885) | 3.78400874 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66035561 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61499059 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61499059 |
| 15 | protein insertion into membrane (GO:0051205) | 3.60721024 |
| 16 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.47048563 |
| 17 | regulation of sequestering of triglyceride (GO:0010889) | 3.46238235 |
| 18 | plasma lipoprotein particle clearance (GO:0034381) | 3.37757034 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.37079723 |
| 20 | protein carboxylation (GO:0018214) | 3.24373491 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.24373491 |
| 22 | hemoglobin metabolic process (GO:0020027) | 3.17890376 |
| 23 | pentose-phosphate shunt (GO:0006098) | 3.17550044 |
| 24 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.13181630 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13050212 |
| 26 | response to host immune response (GO:0052572) | 3.13050212 |
| 27 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.09514187 |
| 28 | negative regulation of protein activation cascade (GO:2000258) | 3.09303224 |
| 29 | negative regulation of complement activation (GO:0045916) | 3.09240298 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.07423867 |
| 31 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.05061714 |
| 32 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.04129230 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 3.03465348 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02479985 |
| 35 | protein-lipid complex assembly (GO:0065005) | 3.00702928 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 2.99873231 |
| 37 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.98759006 |
| 38 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.98759006 |
| 39 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.98504894 |
| 40 | fibrinolysis (GO:0042730) | 2.97017423 |
| 41 | heme biosynthetic process (GO:0006783) | 2.96576936 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 2.94854390 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 2.93764582 |
| 44 | NADPH regeneration (GO:0006740) | 2.92506932 |
| 45 | blood coagulation, intrinsic pathway (GO:0007597) | 2.92290811 |
| 46 | response to host (GO:0075136) | 2.91990449 |
| 47 | response to host defenses (GO:0052200) | 2.91990449 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91990449 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.91225724 |
| 50 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.91100813 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.90785201 |
| 52 | natural killer cell mediated immunity (GO:0002228) | 2.90785201 |
| 53 | apoptotic cell clearance (GO:0043277) | 2.89586581 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 2.87764491 |
| 55 | complement activation, alternative pathway (GO:0006957) | 2.87249890 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86825362 |
| 57 | sulfur amino acid catabolic process (GO:0000098) | 2.85392594 |
| 58 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.83665526 |
| 59 | ethanol oxidation (GO:0006069) | 2.83594993 |
| 60 | iron ion import (GO:0097286) | 2.81755896 |
| 61 | lysine metabolic process (GO:0006553) | 2.81487010 |
| 62 | lysine catabolic process (GO:0006554) | 2.81487010 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.81403331 |
| 64 | positive regulation of receptor recycling (GO:0001921) | 2.81089816 |
| 65 | regulation of platelet activation (GO:0010543) | 2.80830183 |
| 66 | heme metabolic process (GO:0042168) | 2.79487426 |
| 67 | regulation of protein activation cascade (GO:2000257) | 2.79455695 |
| 68 | positive regulation of coagulation (GO:0050820) | 2.77733976 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 2.76537270 |
| 70 | regulation of complement activation (GO:0030449) | 2.76419078 |
| 71 | positive regulation of lipid storage (GO:0010884) | 2.75689540 |
| 72 | regulation of female gonad development (GO:2000194) | 2.73379105 |
| 73 | protein activation cascade (GO:0072376) | 2.73077189 |
| 74 | negative regulation of humoral immune response (GO:0002921) | 2.71662607 |
| 75 | regulation of platelet aggregation (GO:0090330) | 2.70502621 |
| 76 | positive regulation of hemostasis (GO:1900048) | 2.70418906 |
| 77 | positive regulation of blood coagulation (GO:0030194) | 2.70418906 |
| 78 | positive regulation of fatty acid oxidation (GO:0046321) | 2.70098358 |
| 79 | negative regulation of hemostasis (GO:1900047) | 2.68291510 |
| 80 | negative regulation of blood coagulation (GO:0030195) | 2.68291510 |
| 81 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.67384762 |
| 82 | porphyrin-containing compound metabolic process (GO:0006778) | 2.67092737 |
| 83 | complement activation (GO:0006956) | 2.65318175 |
| 84 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.65314091 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.63553060 |
| 86 | protein-lipid complex subunit organization (GO:0071825) | 2.63518119 |
| 87 | plasma lipoprotein particle organization (GO:0071827) | 2.62477744 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 2.62341635 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.61882092 |
| 90 | high-density lipoprotein particle remodeling (GO:0034375) | 2.61503848 |
| 91 | negative regulation of lipid storage (GO:0010888) | 2.59943197 |
| 92 | fatty acid oxidation (GO:0019395) | 2.59861777 |
| 93 | response to thyroid hormone (GO:0097066) | 2.58679953 |
| 94 | regulation of macrophage chemotaxis (GO:0010758) | 2.58679726 |
| 95 | complement activation, classical pathway (GO:0006958) | 2.58431039 |
| 96 | fibril organization (GO:0097435) | 2.58367144 |
| 97 | negative regulation of coagulation (GO:0050819) | 2.56845279 |
| 98 | fatty acid beta-oxidation (GO:0006635) | 2.56152790 |
| 99 | negative regulation of fibrinolysis (GO:0051918) | 2.56070889 |
| 100 | respiratory burst (GO:0045730) | 2.55709033 |
| 101 | brown fat cell differentiation (GO:0050873) | 2.55566358 |
| 102 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.55307812 |
| 103 | lipid oxidation (GO:0034440) | 2.54419525 |
| 104 | defense response to fungus (GO:0050832) | 2.54092715 |
| 105 | cysteine metabolic process (GO:0006534) | 2.53639385 |
| 106 | phospholipid homeostasis (GO:0055091) | 2.53543153 |
| 107 | carnitine metabolic process (GO:0009437) | 2.53540131 |
| 108 | cholesterol efflux (GO:0033344) | 2.53047249 |
| 109 | regulation of blood coagulation (GO:0030193) | 2.52894512 |
| 110 | regulation of hemostasis (GO:1900046) | 2.52894512 |
| 111 | angiogenesis involved in wound healing (GO:0060055) | 2.52465500 |
| 112 | reverse cholesterol transport (GO:0043691) | 2.52422787 |
| 113 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.51600391 |
| 114 | endothelium development (GO:0003158) | 2.51272105 |
| 115 | phospholipid efflux (GO:0033700) | 2.50879120 |
| 116 | response to fungus (GO:0009620) | 2.50607341 |
| 117 | regulation of fatty acid oxidation (GO:0046320) | 2.50247163 |
| 118 | positive regulation of wound healing (GO:0090303) | 2.49558088 |
| 119 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.48991809 |
| 120 | pinocytosis (GO:0006907) | 2.47555851 |
| 121 | response to peptidoglycan (GO:0032494) | 2.47447913 |
| 122 | platelet degranulation (GO:0002576) | 2.47354833 |
| 123 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.47208951 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.46630440 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.46630440 |
| 126 | regulation of triglyceride metabolic process (GO:0090207) | 2.46303776 |
| 127 | negative regulation of granulocyte differentiation (GO:0030853) | 2.46144997 |
| 128 | ethanol metabolic process (GO:0006067) | 2.45301091 |
| 129 | negative regulation of platelet activation (GO:0010544) | 2.45226197 |
| 130 | macromolecular complex remodeling (GO:0034367) | 2.44682131 |
| 131 | plasma lipoprotein particle remodeling (GO:0034369) | 2.44682131 |
| 132 | regulation of coagulation (GO:0050818) | 2.42585722 |
| 133 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.42256788 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 2.41900549 |
| 135 | extracellular fibril organization (GO:0043206) | 2.41597301 |
| 136 | hyaluronan catabolic process (GO:0030214) | 2.40129788 |
| 137 | surfactant homeostasis (GO:0043129) | 2.39443250 |
| 138 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.37698070 |
| 139 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.35253273 |
| 140 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.34945282 |
| 141 | acute-phase response (GO:0006953) | 2.33802330 |
| 142 | barbed-end actin filament capping (GO:0051016) | 2.32611675 |
| 143 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.32577217 |
| 144 | detection of molecule of bacterial origin (GO:0032490) | 2.31498956 |
| 145 | thrombin receptor signaling pathway (GO:0070493) | 2.30888998 |
| 146 | low-density lipoprotein particle remodeling (GO:0034374) | 2.30736136 |
| 147 | negative regulation of wound healing (GO:0061045) | 2.28887225 |
| 148 | regulation of apoptotic cell clearance (GO:2000425) | 2.28350642 |
| 149 | regulation of humoral immune response (GO:0002920) | 2.28202369 |
| 150 | gas transport (GO:0015669) | 2.27023634 |
| 151 | positive regulation of osteoblast proliferation (GO:0033690) | 2.25991525 |
| 152 | peptide catabolic process (GO:0043171) | 2.25550428 |
| 153 | triglyceride catabolic process (GO:0019433) | 2.25409647 |
| 154 | platelet aggregation (GO:0070527) | 2.23988128 |
| 155 | detection of external biotic stimulus (GO:0098581) | 2.23960485 |
| 156 | detection of other organism (GO:0098543) | 2.23146095 |
| 157 | regulation of fibrinolysis (GO:0051917) | 2.22895228 |
| 158 | oxygen transport (GO:0015671) | 2.19598505 |
| 159 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.18339895 |
| 160 | keratan sulfate catabolic process (GO:0042340) | 2.17874491 |
| 161 | adhesion of symbiont to host cell (GO:0044650) | 2.17679288 |
| 162 | virion attachment to host cell (GO:0019062) | 2.17679288 |
| 163 | cellular extravasation (GO:0045123) | 2.17074627 |
| 164 | regulation of integrin activation (GO:0033623) | 2.14810995 |
| 165 | positive regulation of cholesterol efflux (GO:0010875) | 2.14194105 |
| 166 | detection of bacterium (GO:0016045) | 2.14091028 |
| 167 | nitrogen cycle metabolic process (GO:0071941) | 2.13860931 |
| 168 | adhesion of symbiont to host (GO:0044406) | 2.13348358 |
| 169 | megakaryocyte development (GO:0035855) | 2.11703319 |
| 170 | hypotonic response (GO:0006971) | 2.11256394 |
| 171 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.10573933 |
| 172 | negative regulation of focal adhesion assembly (GO:0051895) | 2.09775899 |
| 173 | negative regulation of cell junction assembly (GO:1901889) | 2.09775899 |
| 174 | negative regulation of adherens junction organization (GO:1903392) | 2.09775899 |
| 175 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.09414330 |
| 176 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.09267183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.56153819 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.46205908 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42063450 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.20579055 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.18195204 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82080828 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.61171619 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59083642 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.54756626 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.51546087 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47003242 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46472673 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35608774 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34700753 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27723348 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27658003 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26046177 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24669604 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17917550 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16678397 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13212470 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12743025 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11870182 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08949496 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.08310392 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01394211 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99359882 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92999043 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92128599 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87341131 |
| 31 | GATA1_19941826_ChIP-Seq_K562_Human | 1.86356370 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84363703 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.83940687 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83703947 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73850494 |
| 36 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.71459151 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.70840803 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69676195 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65134871 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57928559 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56892127 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56495159 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56000854 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.54490367 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52441726 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51405656 |
| 47 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50634519 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49577367 |
| 49 | GATA2_19941826_ChIP-Seq_K562_Human | 1.47390112 |
| 50 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47119170 |
| 51 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46051141 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45724947 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43992606 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42837771 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41947820 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.41903293 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40524415 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39584638 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39114948 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38486068 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37984255 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35736244 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34920914 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29700187 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29412392 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28495281 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.28254130 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25334110 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23505868 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23265316 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22299383 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21952125 |
| 73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21837403 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.21200376 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20828142 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19340315 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17937900 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17816137 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16607245 |
| 80 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15973078 |
| 81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15925475 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15848806 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.15161012 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14949100 |
| 85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13441170 |
| 86 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12941016 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12536839 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12367579 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.12191990 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10988828 |
| 91 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10808603 |
| 92 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10808603 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10418983 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10417992 |
| 95 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10082336 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08464818 |
| 97 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07702637 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07170681 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07170681 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07159898 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06926235 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06824631 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05702180 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04312303 |
| 105 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.04203196 |
| 106 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02363670 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02167723 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01849204 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00287719 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99742573 |
| 111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99427965 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98887148 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98034355 |
| 114 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97174599 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97141436 |
| 116 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97080139 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96699821 |
| 118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96084425 |
| 119 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96050064 |
| 120 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96050064 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95690699 |
| 122 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95011338 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94659090 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93141053 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92230976 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91890591 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91501590 |
| 128 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90764103 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90458316 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90090143 |
| 131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88869647 |
| 132 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86553464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 4.62441543 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 3.23836224 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.98594822 |
| 4 | MP0009840_abnormal_foam_cell | 2.92567094 |
| 5 | MP0005360_urolithiasis | 2.68951743 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.67930520 |
| 7 | MP0003303_peritoneal_inflammation | 2.63685253 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.46314940 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.27128481 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.25740145 |
| 11 | MP0003436_decreased_susceptibility_to | 2.14304977 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.06089020 |
| 13 | MP0008004_abnormal_stomach_pH | 2.05356367 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02135978 |
| 15 | MP0004147_increased_porphyrin_level | 1.98520723 |
| 16 | MP0005365_abnormal_bile_salt | 1.96399136 |
| 17 | MP0006054_spinal_hemorrhage | 1.91465094 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.88846552 |
| 19 | MP0003724_increased_susceptibility_to | 1.81147250 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 1.75416981 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.72901019 |
| 22 | MP0003828_pulmonary_edema | 1.69832520 |
| 23 | MP0004130_abnormal_muscle_cell | 1.69317446 |
| 24 | MP0002419_abnormal_innate_immunity | 1.68100374 |
| 25 | MP0000343_altered_response_to | 1.67859354 |
| 26 | MP0003252_abnormal_bile_duct | 1.66575597 |
| 27 | MP0003279_aneurysm | 1.66249905 |
| 28 | MP0005083_abnormal_biliary_tract | 1.65391074 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 1.64578887 |
| 30 | MP0000609_abnormal_liver_physiology | 1.61252596 |
| 31 | MP0009785_altered_susceptibility_to | 1.59466082 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.58178473 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.52461909 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.50970047 |
| 35 | MP0006082_CNS_inflammation | 1.48616422 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.47373355 |
| 37 | MP0000604_amyloidosis | 1.46392883 |
| 38 | MP0004272_abnormal_basement_membrane | 1.42341158 |
| 39 | MP0005025_abnormal_response_to | 1.38862166 |
| 40 | MP0003091_abnormal_cell_migration | 1.36876374 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.35126700 |
| 42 | MP0009764_decreased_sensitivity_to | 1.35002784 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.34991626 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.34991626 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.30053968 |
| 46 | MP0004510_myositis | 1.28380290 |
| 47 | MP0008469_abnormal_protein_level | 1.27969324 |
| 48 | MP0003075_altered_response_to | 1.25681825 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25314896 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.24230821 |
| 51 | MP0003186_abnormal_redox_activity | 1.24026680 |
| 52 | MP0004883_abnormal_blood_vessel | 1.22136878 |
| 53 | MP0008260_abnormal_autophagy | 1.21344419 |
| 54 | MP0005503_abnormal_tendon_morphology | 1.20921230 |
| 55 | MP0010307_abnormal_tumor_latency | 1.19597405 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.18930882 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.16312497 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.15153070 |
| 59 | MP0009278_abnormal_bone_marrow | 1.14586343 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.14174804 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.12450707 |
| 62 | MP0000685_abnormal_immune_system | 1.12333444 |
| 63 | MP0005670_abnormal_white_adipose | 1.11476663 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.10619526 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.10371614 |
| 66 | MP0004947_skin_inflammation | 1.09432474 |
| 67 | MP0001790_abnormal_immune_system | 1.09088147 |
| 68 | MP0005387_immune_system_phenotype | 1.09088147 |
| 69 | MP0002405_respiratory_system_inflammati | 1.07929586 |
| 70 | MP0009763_increased_sensitivity_to | 1.07537480 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.07028253 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.04758637 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 1.04255730 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.02290459 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 1.02207099 |
| 76 | MP0001853_heart_inflammation | 1.01557061 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.01359528 |
| 78 | MP0001666_abnormal_nutrient_absorption | 1.01352885 |
| 79 | MP0000598_abnormal_liver_morphology | 1.00526322 |
| 80 | MP0005166_decreased_susceptibility_to | 0.98782935 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.97407963 |
| 82 | MP0002971_abnormal_brown_adipose | 0.97389028 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.96758973 |
| 84 | MP0005390_skeleton_phenotype | 0.96201368 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 0.96053268 |
| 86 | MP0005451_abnormal_body_composition | 0.95650876 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.95511900 |
| 88 | MP0001800_abnormal_humoral_immune | 0.92907159 |
| 89 | MP0003690_abnormal_glial_cell | 0.92881105 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.92230217 |
| 91 | MP0000858_altered_metastatic_potential | 0.90195772 |
| 92 | MP0001849_ear_inflammation | 0.90121410 |
| 93 | MP0002933_joint_inflammation | 0.89027316 |
| 94 | MP0009115_abnormal_fat_cell | 0.88734744 |
| 95 | MP0005165_increased_susceptibility_to | 0.87531127 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.86827457 |
| 97 | MP0006138_congestive_heart_failure | 0.86748068 |
| 98 | MP0002723_abnormal_immune_serum | 0.86442038 |
| 99 | MP0000249_abnormal_blood_vessel | 0.86261381 |
| 100 | MP0003045_fibrosis | 0.85080935 |
| 101 | MP0002148_abnormal_hypersensitivity_rea | 0.85015069 |
| 102 | MP0001819_abnormal_immune_cell | 0.84119648 |
| 103 | MP0005164_abnormal_response_to | 0.83153161 |
| 104 | MP0000490_abnormal_crypts_of | 0.83057912 |
| 105 | MP0002420_abnormal_adaptive_immunity | 0.82480471 |
| 106 | MP0003646_muscle_fatigue | 0.80691252 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.80419185 |
| 108 | MP0008775_abnormal_heart_ventricle | 0.80281075 |
| 109 | MP0003448_altered_tumor_morphology | 0.79848831 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.79523513 |
| 111 | MP0005275_abnormal_skin_tensile | 0.78593023 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.77352143 |
| 113 | MP0005023_abnormal_wound_healing | 0.76797118 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.76647730 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.75488567 |
| 116 | MP0001958_emphysema | 0.74918709 |
| 117 | MP0008873_increased_physiological_sensi | 0.73206199 |
| 118 | MP0005076_abnormal_cell_differentiation | 0.72732480 |
| 119 | MP0001851_eye_inflammation | 0.72190544 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.72053692 |
| 121 | MP0001542_abnormal_bone_strength | 0.71509188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 4.21145519 |
| 2 | Purpura (HP:0000979) | 4.09596482 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 3.79065779 |
| 4 | Increased mean platelet volume (HP:0011877) | 3.73525182 |
| 5 | Menorrhagia (HP:0000132) | 3.69851741 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.65776670 |
| 7 | Gingival bleeding (HP:0000225) | 3.64236273 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.57360349 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.56045982 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.55694765 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.52240274 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47359788 |
| 13 | Petechiae (HP:0000967) | 3.41970224 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.18817524 |
| 15 | Xanthomatosis (HP:0000991) | 3.18787805 |
| 16 | Complement deficiency (HP:0004431) | 3.13048060 |
| 17 | Aortic aneurysm (HP:0004942) | 3.12731517 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.10766366 |
| 19 | Myocardial infarction (HP:0001658) | 2.99826326 |
| 20 | * Poikilocytosis (HP:0004447) | 2.98734589 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97930960 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97930960 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97930960 |
| 24 | Orchitis (HP:0100796) | 2.92749773 |
| 25 | Myositis (HP:0100614) | 2.92717382 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.92326134 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.89302913 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 2.88576526 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 2.86949920 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84778054 |
| 31 | Abnormality of complement system (HP:0005339) | 2.82929482 |
| 32 | Reticulocytosis (HP:0001923) | 2.81078478 |
| 33 | Nasal polyposis (HP:0100582) | 2.78660032 |
| 34 | Joint hemorrhage (HP:0005261) | 2.77393169 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.76344693 |
| 36 | Polycythemia (HP:0001901) | 2.74768309 |
| 37 | Increased serum ferritin (HP:0003281) | 2.70726796 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 2.69496460 |
| 39 | Cholelithiasis (HP:0001081) | 2.69262078 |
| 40 | Abnormality of iron homeostasis (HP:0011031) | 2.61018858 |
| 41 | Palpitations (HP:0001962) | 2.58068070 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.52827795 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52827795 |
| 44 | Vascular tortuosity (HP:0004948) | 2.50360418 |
| 45 | Acanthocytosis (HP:0001927) | 2.46997697 |
| 46 | Amyloidosis (HP:0011034) | 2.43100255 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.41737950 |
| 48 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40943103 |
| 49 | Osteolytic defects of the hand bones (HP:0009699) | 2.40943103 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.40847721 |
| 51 | Axonal loss (HP:0003447) | 2.40116354 |
| 52 | Cholecystitis (HP:0001082) | 2.40046609 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.40046609 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.39248982 |
| 55 | Esophageal varix (HP:0002040) | 2.36754402 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36110491 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36110491 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36110491 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.35690066 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.34692858 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.34134965 |
| 62 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.33756221 |
| 63 | Peritonitis (HP:0002586) | 2.33071146 |
| 64 | Urticaria (HP:0001025) | 2.32462375 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.31184538 |
| 66 | Aortic dissection (HP:0002647) | 2.30624794 |
| 67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30532565 |
| 68 | Disinhibition (HP:0000734) | 2.29912806 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.29673289 |
| 70 | Hypolipoproteinemia (HP:0010981) | 2.28359966 |
| 71 | Hematochezia (HP:0002573) | 2.28328495 |
| 72 | Hepatocellular carcinoma (HP:0001402) | 2.28200961 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.26100107 |
| 74 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.26040808 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.24345567 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24032651 |
| 77 | Nausea (HP:0002018) | 2.23992592 |
| 78 | Neoplasm of head and neck (HP:0012288) | 2.23542759 |
| 79 | Esophageal neoplasm (HP:0100751) | 2.23542759 |
| 80 | Mitral stenosis (HP:0001718) | 2.22001403 |
| 81 | Hyperbilirubinemia (HP:0002904) | 2.18273444 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.17671867 |
| 83 | Tetraparesis (HP:0002273) | 2.16068974 |
| 84 | Loss of speech (HP:0002371) | 2.16014498 |
| 85 | Pustule (HP:0200039) | 2.14656344 |
| 86 | Hyperammonemia (HP:0001987) | 2.14330742 |
| 87 | Arterial tortuosity (HP:0005116) | 2.13895804 |
| 88 | Global brain atrophy (HP:0002283) | 2.10725669 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.10325770 |
| 90 | Optic neuritis (HP:0100653) | 2.08760739 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.08760739 |
| 92 | Microcytic anemia (HP:0001935) | 2.07611711 |
| 93 | Myoglobinuria (HP:0002913) | 2.07574521 |
| 94 | Conjunctival hamartoma (HP:0100780) | 2.07361912 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06902720 |
| 96 | Hypertriglyceridemia (HP:0002155) | 2.06382150 |
| 97 | Bruising susceptibility (HP:0000978) | 2.02395695 |
| 98 | Glomerulonephritis (HP:0000099) | 2.02175468 |
| 99 | Mucosal telangiectasiae (HP:0100579) | 2.01781010 |
| 100 | Joint swelling (HP:0001386) | 2.00550448 |
| 101 | Aneurysm (HP:0002617) | 1.99708313 |
| 102 | Nephritis (HP:0000123) | 1.98436956 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.97921396 |
| 104 | Cerebral aneurysm (HP:0004944) | 1.97567223 |
| 105 | Impaired platelet aggregation (HP:0003540) | 1.97166957 |
| 106 | Abnormal platelet function (HP:0011869) | 1.97166957 |
| 107 | Pulmonary embolism (HP:0002204) | 1.96794958 |
| 108 | Gingivitis (HP:0000230) | 1.96608566 |
| 109 | Nonimmune hydrops fetalis (HP:0001790) | 1.95666440 |
| 110 | Paralysis (HP:0003470) | 1.94723799 |
| 111 | Thrombophlebitis (HP:0004418) | 1.94073316 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93910818 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 1.93822023 |
| 114 | Arterial thrombosis (HP:0004420) | 1.93657540 |
| 115 | Increased density of long bones (HP:0006392) | 1.93183247 |
| 116 | Rhabdomyolysis (HP:0003201) | 1.93103645 |
| 117 | Abnormality of macular pigmentation (HP:0008002) | 1.91839516 |
| 118 | Right ventricular cardiomyopathy (HP:0011663) | 1.91632158 |
| 119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91573284 |
| 120 | Hypobetalipoproteinemia (HP:0003563) | 1.91329576 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 1.90741913 |
| 122 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90632599 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 1.89865587 |
| 124 | Hydroxyprolinuria (HP:0003080) | 1.89865587 |
| 125 | Epistaxis (HP:0000421) | 1.88870917 |
| 126 | Wormian bones (HP:0002645) | 1.88717157 |
| 127 | Conjunctival telangiectasia (HP:0000524) | 1.87786738 |
| 128 | Spondylolisthesis (HP:0003302) | 1.83214472 |
| 129 | Cervical subluxation (HP:0003308) | 1.80412552 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77129158 |
| 131 | Muscle fiber splitting (HP:0003555) | 1.76834614 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.74767532 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.74376599 |
| 134 | Keratoconjunctivitis sicca (HP:0001097) | 1.73112273 |
| 135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71255453 |
| 136 | Skin nodule (HP:0200036) | 1.71134409 |
| 137 | Hepatosplenomegaly (HP:0001433) | 1.69950448 |
| 138 | Cardiovascular calcification (HP:0011915) | 1.68401076 |
| 139 | Gastrointestinal infarctions (HP:0005244) | 1.64857311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.13683397 |
| 2 | ERN1 | 3.66454557 |
| 3 | TAOK3 | 3.34731613 |
| 4 | PKN2 | 3.02793434 |
| 5 | PRPF4B | 2.61155310 |
| 6 | TTN | 2.56028377 |
| 7 | TBK1 | 2.29429739 |
| 8 | RIPK1 | 2.25113132 |
| 9 | EEF2K | 2.18259766 |
| 10 | TGFBR2 | 2.13425952 |
| 11 | CAMK1D | 2.08577208 |
| 12 | KDR | 2.03429576 |
| 13 | TYK2 | 1.94114478 |
| 14 | RIPK4 | 1.81430992 |
| 15 | TAOK2 | 1.72510792 |
| 16 | GRK7 | 1.69011139 |
| 17 | MAP2K3 | 1.64200671 |
| 18 | KIT | 1.60341051 |
| 19 | DDR2 | 1.53823494 |
| 20 | EPHB1 | 1.53769869 |
| 21 | JAK1 | 1.52997405 |
| 22 | MAPKAPK3 | 1.52113604 |
| 23 | STK10 | 1.49618237 |
| 24 | SIK1 | 1.46599542 |
| 25 | STK24 | 1.46173634 |
| 26 | PHKG2 | 1.46047154 |
| 27 | PHKG1 | 1.46047154 |
| 28 | PDGFRA | 1.44161365 |
| 29 | IRAK3 | 1.43965438 |
| 30 | TRPM7 | 1.42783663 |
| 31 | LRRK2 | 1.37807097 |
| 32 | PIM2 | 1.37574155 |
| 33 | PTK6 | 1.36653545 |
| 34 | FLT3 | 1.34779901 |
| 35 | BCKDK | 1.31492548 |
| 36 | EIF2AK1 | 1.31139671 |
| 37 | CAMK1G | 1.27473571 |
| 38 | BMPR2 | 1.22464020 |
| 39 | FER | 1.22153924 |
| 40 | MAP4K1 | 1.20724197 |
| 41 | MAP3K3 | 1.17527873 |
| 42 | MAP3K10 | 1.16011444 |
| 43 | FES | 1.13730816 |
| 44 | MAP3K14 | 1.12631379 |
| 45 | GRK5 | 1.11628628 |
| 46 | MAP3K1 | 1.08509338 |
| 47 | NEK9 | 1.07259761 |
| 48 | STK3 | 1.06301030 |
| 49 | RPS6KA4 | 1.05117955 |
| 50 | GRK6 | 1.04225653 |
| 51 | CDC42BPA | 1.03479494 |
| 52 | JAK2 | 1.02587314 |
| 53 | CDK6 | 1.00985211 |
| 54 | MATK | 0.99295373 |
| 55 | FGFR4 | 0.98586757 |
| 56 | IKBKE | 0.95865647 |
| 57 | IRAK4 | 0.92697611 |
| 58 | ZAP70 | 0.91654433 |
| 59 | PDGFRB | 0.90757795 |
| 60 | BLK | 0.89981059 |
| 61 | IRAK1 | 0.88786423 |
| 62 | TIE1 | 0.87857249 |
| 63 | JAK3 | 0.86917488 |
| 64 | BMX | 0.86146161 |
| 65 | MST1R | 0.83355574 |
| 66 | PIM1 | 0.83322331 |
| 67 | TAOK1 | 0.83103665 |
| 68 | MAPK11 | 0.82450966 |
| 69 | FGR | 0.82258116 |
| 70 | CSK | 0.81988773 |
| 71 | PRKAA2 | 0.81940638 |
| 72 | PDPK1 | 0.79638079 |
| 73 | ILK | 0.78485630 |
| 74 | MAPK12 | 0.75547584 |
| 75 | CDK12 | 0.73194213 |
| 76 | TXK | 0.72643585 |
| 77 | MAP3K2 | 0.70945356 |
| 78 | MARK3 | 0.70323133 |
| 79 | ACVR1B | 0.70140826 |
| 80 | BTK | 0.69873493 |
| 81 | MAP3K6 | 0.69707813 |
| 82 | CAMKK2 | 0.68269901 |
| 83 | STK4 | 0.67816079 |
| 84 | PDK2 | 0.67102687 |
| 85 | MAP3K13 | 0.66956830 |
| 86 | TESK1 | 0.66531290 |
| 87 | LYN | 0.65706678 |
| 88 | DYRK1B | 0.65619398 |
| 89 | EPHA3 | 0.65241599 |
| 90 | PAK2 | 0.64456534 |
| 91 | CLK1 | 0.63867668 |
| 92 | FGFR3 | 0.63688540 |
| 93 | CSF1R | 0.63656937 |
| 94 | HCK | 0.62921441 |
| 95 | MAPK7 | 0.62286684 |
| 96 | PAK4 | 0.62210111 |
| 97 | SCYL2 | 0.62051065 |
| 98 | ABL2 | 0.61826755 |
| 99 | HIPK2 | 0.61513805 |
| 100 | PTK2 | 0.61224284 |
| 101 | PRKD1 | 0.60386495 |
| 102 | LMTK2 | 0.60262673 |
| 103 | MAPKAPK2 | 0.58314824 |
| 104 | MAPK4 | 0.57253159 |
| 105 | MAP3K5 | 0.56190350 |
| 106 | TEC | 0.54856590 |
| 107 | EGFR | 0.54392516 |
| 108 | IKBKB | 0.54073278 |
| 109 | LCK | 0.53680593 |
| 110 | ICK | 0.53488191 |
| 111 | NUAK1 | 0.52489115 |
| 112 | MAP3K8 | 0.52331671 |
| 113 | CDK4 | 0.52236180 |
| 114 | SYK | 0.52193017 |
| 115 | MOS | 0.51713333 |
| 116 | PRKG2 | 0.51477954 |
| 117 | ADRBK1 | 0.50383462 |
| 118 | NLK | 0.50278106 |
| 119 | MAP3K11 | 0.50044727 |
| 120 | RPS6KA2 | 0.49883108 |
| 121 | SGK3 | 0.49785550 |
| 122 | PDK1 | 0.48930675 |
| 123 | GSK3A | 0.48575753 |
| 124 | KSR2 | 0.47169548 |
| 125 | DMPK | 0.46104645 |
| 126 | IGF1R | 0.45029811 |
| 127 | PAK3 | 0.44851175 |
| 128 | ABL1 | 0.43871377 |
| 129 | PTK2B | 0.43570857 |
| 130 | CDK9 | 0.43366804 |
| 131 | RET | 0.43183129 |
| 132 | PIK3CG | 0.41462493 |
| 133 | PRKAA1 | 0.41261062 |
| 134 | NEK2 | 0.41178227 |
| 135 | ERBB3 | 0.40740587 |
| 136 | ITK | 0.40523967 |
| 137 | NME2 | 0.40183376 |
| 138 | MYLK | 0.38583024 |
| 139 | MAP2K2 | 0.38460093 |
| 140 | RPS6KA6 | 0.38267817 |
| 141 | MAP3K7 | 0.37484788 |
| 142 | CAMK2D | 0.37263400 |
| 143 | MAP2K1 | 0.35846651 |
| 144 | DAPK2 | 0.34667463 |
| 145 | NEK1 | 0.34535100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.30502289 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.84855172 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61227850 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48347985 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32700967 |
| 6 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.07151784 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07120311 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02954003 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.96517386 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86326947 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84564341 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73087345 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70667889 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69383110 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.65224976 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61643694 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60248731 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57822278 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.57402405 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56627664 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.53635024 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.52830254 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52274684 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51783048 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49967069 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49364587 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41792767 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40245898 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39090547 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35731824 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.30837107 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30195729 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.28342908 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27511462 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23884039 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.23641056 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20747512 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20156685 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18869948 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.17523506 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.16281302 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16125744 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13763949 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08791610 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04543000 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04138345 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.03875995 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.02356543 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01748850 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99189692 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.98343831 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.97099473 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96858291 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 0.96165424 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.95767277 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94587508 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.93244111 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.92324234 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91604782 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88315243 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.86544481 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85053334 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84448667 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84111931 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83021755 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82650183 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82231524 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81860203 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81464679 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80266683 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79105681 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78157232 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73652018 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73453827 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.71716067 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.71037900 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70995951 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70019945 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69680652 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69082584 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69007980 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67951760 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66052510 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63380145 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62896048 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62823092 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62657196 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61790213 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59016408 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.58944809 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58822232 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58298031 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57625259 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57271164 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.56538652 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56465015 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56438302 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55984446 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.55372440 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.54138436 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53581480 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53468062 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.52524819 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51445932 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51383465 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50474831 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50129741 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48928090 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48807081 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.48727458 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47863624 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47440594 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47378736 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47199705 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.47163554 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47122486 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46703844 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46667970 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46611075 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.45740443 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45509330 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45459466 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.44279835 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44279413 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43989120 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.42710527 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41210054 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40579886 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39716151 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39020608 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38675519 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36571771 |

